O	O	O	0	9	Induction	Induction	B-NP	NN	O	12	NMOD	O
O	O	O	10	12	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	13	22	monocytic	monocytic	B-NP	JJ	O	4	NMOD	O
O	O	O	23	38	differentiation	differentiation	I-NP	NN	O	9	NMOD	O
O	O	O	39	42	and	and	I-NP	CC	O	9	NMOD	O
T7	B-Entity	B-Entity	43	45	NF	NF	I-NP	NN	B-protein	9	NMOD	B-protein
T7	I-Entity	I-Entity	45	46	-	-	O	HYPH	I-protein	9	P	I-protein
T7	I-Entity	I-Entity	46	51	kappa	kappa	B-NP	NN	I-protein	9	NMOD	I-protein
T7	I-Entity	I-Entity	52	53	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	53	54	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	54	58	like	like	I-NP	JJ	O	12	NMOD	O
O	O	O	59	69	activities	activity	I-NP	NNS	O	0	ROOT	O
O	O	O	70	72	by	by	B-PP	IN	O	12	NMOD	O
O	O	O	73	78	human	human	B-NP	JJ	O	18	NMOD	O
O	O	O	79	95	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD	O
O	O	O	96	101	virus	virus	I-NP	NN	O	18	NMOD	O
O	O	O	102	103	1	1	I-NP	CD	O	18	NMOD	O
O	O	O	104	113	infection	infection	I-NP	NN	O	13	PMOD	O
O	O	O	114	116	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	117	133	myelomonoblastic	myelomonoblastic	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	O	134	139	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	139	140	.	.	O	.	O	12	P	O

O	O	O	142	145	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	146	153	effects	effect	I-NP	NNS	O	25	SUB	O
O	O	O	154	156	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	157	162	human	human	B-NP	JJ	O	6	NMOD	O
O	O	O	163	179	immunodeficiency	immunodeficiency	I-NP	NN	O	6	NMOD	O
O	O	O	180	185	virus	virus	I-NP	NN	O	13	NMOD	O
O	O	O	186	187	1	1	I-NP	CD	O	6	NMOD	O
O	O	O	188	189	(	(	O	(	O	12	DEP	O
O	O	O	189	192	HIV	HIV	B-NP	NN	O	11	SUB	O
O	O	O	192	193	-	-	B-NP	HYPH	O	11	P	O
O	O	O	193	194	1	1	I-NP	CD	O	12	DEP	O
O	O	O	194	195	)	)	O	)	O	6	NMOD	O
O	O	O	196	205	infection	infection	B-NP	NN	O	3	PMOD	O
O	O	O	206	208	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	209	217	cellular	cellular	B-NP	JJ	O	16	NMOD	O
O	O	O	218	233	differentiation	differentiation	I-NP	NN	O	24	NMOD	O
O	O	O	234	237	and	and	I-NP	CC	O	24	NMOD	O
T8	B-Entity	B-Entity	238	240	NF	NF	I-NP	NN	B-protein	24	NMOD	B-protein
T8	I-Entity	I-Entity	240	241	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T8	I-Entity	I-Entity	241	246	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T8	I-Entity	I-Entity	247	248	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T9	I-Entity	I-Entity	249	252	DNA	DNA	I-NP	NN	O	24	NMOD	O
O	O	O	253	260	binding	binding	I-NP	NN	O	24	NMOD	O
O	O	O	261	269	activity	activity	I-NP	NN	O	14	PMOD	O
O	O	O	270	274	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	275	279	been	be	I-VP	VBN	O	25	VC	O
O	O	O	280	292	investigated	investigate	I-VP	VBN	O	26	VC	O
O	O	O	293	295	in	in	B-PP	IN	O	27	VMOD	O
O	O	O	296	297	a	a	B-NP	DT	O	31	NMOD	O
O	O	O	298	301	new	new	I-NP	JJ	O	31	NMOD	O
O	O	O	302	307	model	model	I-NP	NN	O	28	PMOD	O
O	O	O	308	310	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	311	318	myeloid	myeloid	B-NP	JJ	O	34	NMOD	O
O	O	O	319	334	differentiation	differentiation	I-NP	NN	O	32	PMOD	O
O	O	O	334	335	.	.	O	.	O	25	P	O

O	O	O	336	339	PLB	PLB	B-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	339	340	-	-	I-NP	HYPH	I-cell_line	4	NMOD	I-cell_line
O	O	O	340	343	985	985	I-NP	CD	I-cell_line	4	NMOD	I-cell_line
O	O	O	344	349	cells	cell	I-NP	NNS	I-cell_line	5	SUB	I-cell_line
O	O	O	350	359	represent	represent	B-VP	VBP	O	0	ROOT	O
O	O	O	360	361	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	362	373	bipotential	bipotential	I-NP	JJ	B-cell_line	10	NMOD	B-cell_line
O	O	O	374	390	myelomonoblastic	myelomonoblastic	I-NP	JJ	I-cell_line	10	NMOD	I-cell_line
O	O	O	391	395	cell	cell	I-NP	NN	I-cell_line	10	NMOD	I-cell_line
O	O	O	396	406	population	population	I-NP	NN	I-cell_line	5	OBJ	I-cell_line
O	O	O	407	414	capable	capable	B-ADJP	JJ	O	10	NMOD	O
O	O	O	415	417	of	of	B-PP	IN	O	11	AMOD	O
O	O	O	418	424	either	either	B-NP	CC	O	16	AMOD	O
O	O	O	425	437	granulocytic	granulocytic	I-NP	JJ	O	16	AMOD	O
O	O	O	438	440	or	or	I-NP	CC	O	16	AMOD	O
O	O	O	441	450	monocytic	monocytic	I-NP	JJ	O	17	NMOD	O
O	O	O	451	466	differentiation	differentiation	I-NP	NN	O	12	PMOD	O
O	O	O	467	472	after	after	B-PP	IN	O	5	VMOD	O
O	O	O	473	482	induction	induction	B-NP	NN	O	18	PMOD	O
O	O	O	483	487	with	with	B-PP	IN	O	19	NMOD	O
O	O	O	488	499	appropriate	appropriate	B-NP	JJ	O	22	NMOD	O
O	O	O	500	508	inducers	inducer	I-NP	NNS	O	20	PMOD	O
O	O	O	508	509	.	.	O	.	O	5	P	O

O	O	O	510	512	By	By	B-PP	IN	O	17	VMOD	O
O	O	O	513	519	virtue	virtue	B-NP	NN	O	1	PMOD	O
O	O	O	520	522	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	523	526	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	527	535	presence	presence	I-NP	NN	O	3	PMOD	O
O	O	O	536	538	of	of	B-PP	IN	O	5	NMOD	O
T1	B-Protein	B-Protein	539	542	CD4	CD4	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	O	543	545	on	on	B-PP	IN	O	1	PMOD	O
O	O	O	546	549	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	550	554	cell	cell	I-NP	NN	O	11	NMOD	O
O	O	O	555	562	surface	surface	I-NP	NN	O	8	PMOD	O
O	O	O	562	563	,	,	O	,	O	17	P	O
O	O	O	564	567	PLB	PLB	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	O	567	568	-	-	B-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	568	571	985	985	I-NP	CD	I-cell_line	16	NMOD	I-cell_line
O	O	O	572	577	cells	cell	I-NP	NNS	I-cell_line	17	SUB	I-cell_line
O	O	O	578	582	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	583	594	chronically	chronically	I-VP	RB	O	17	VMOD	O
O	O	O	595	603	infected	infect	I-VP	VBN	O	17	VC	O
O	O	O	604	608	with	with	B-PP	IN	O	19	VMOD	O
O	O	O	609	612	HIV	HIV	B-NP	NN	O	25	NMOD	O
O	O	O	612	613	-	-	B-NP	HYPH	O	25	NMOD	O
O	O	O	613	614	1	1	I-NP	CD	O	25	NMOD	O
O	O	O	615	621	strain	strain	I-NP	NN	O	25	NMOD	O
O	O	O	622	626	IIIB	IIIB	I-NP	NN	O	20	PMOD	O
O	O	O	626	627	.	.	O	.	O	17	P	O

O	O	O	628	631	PLB	PLB	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	631	632	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	632	636	IIIB	IIIB	I-NP	NN	B-cell_line	4	NMOD	B-cell_line
O	O	O	637	642	cells	cell	I-NP	NNS	I-cell_line	6	SUB	I-cell_line
O	O	O	643	650	clearly	clearly	B-ADVP	RB	O	6	VMOD	O
O	O	O	651	660	possessed	possess	B-VP	VBD	O	0	ROOT	O
O	O	O	661	662	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	663	667	more	more	I-NP	RBR	O	9	AMOD	O
O	O	O	668	677	monocytic	monocytic	I-NP	JJ	O	10	NMOD	O
O	O	O	678	687	phenotype	phenotype	I-NP	NN	O	6	OBJ	O
O	O	O	688	692	than	than	B-PP	IN	O	10	NMOD	O
O	O	O	693	696	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	697	705	parental	parental	I-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	706	717	myeloblasts	myeloblast	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	717	718	,	,	O	,	O	6	P	O
O	O	O	719	721	as	as	B-SBAR	IN	O	6	VMOD	O
O	O	O	722	732	determined	determine	B-VP	VBN	O	16	SBAR	O
O	O	O	733	735	by	by	B-PP	IN	O	17	VMOD	O
O	O	O	736	748	differential	differential	B-NP	JJ	O	20	NMOD	O
O	O	O	749	757	staining	staining	I-NP	NN	O	23	NMOD	O
O	O	O	757	758	,	,	O	,	O	23	P	O
O	O	O	759	768	increased	increase	B-NP	VBN	O	23	NMOD	O
O	O	O	769	779	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	O	780	782	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	783	786	the	the	B-NP	DT	O	30	NMOD	O
O	O	O	787	794	myeloid	myeloid	I-NP	JJ	B-protein	30	NMOD	B-protein
O	O	O	794	795	-	-	I-NP	HYPH	I-protein	30	NMOD	I-protein
O	O	O	795	803	specific	specific	I-NP	JJ	I-protein	30	NMOD	I-protein
O	O	O	804	811	surface	surface	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	812	819	markers	marker	I-NP	NNS	I-protein	24	PMOD	I-protein
O	O	O	819	820	,	,	O	,	O	33	P	O
O	O	O	821	824	and	and	O	CC	O	33	NMOD	O
O	O	O	825	838	transcription	transcription	B-NP	NN	O	6	VMOD	O
O	O	O	839	841	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	842	845	the	the	B-NP	DT	O	38	NMOD	O
T2	B-Protein	B-Protein	846	847	c	c	I-NP	NN	B-DNA	38	NMOD	B-DNA
T2	I-Protein	I-Protein	847	848	-	-	B-NP	HYPH	I-DNA	38	P	I-DNA
T2	I-Protein	I-Protein	848	851	fms	fm	I-NP	NNS	I-DNA	34	PMOD	I-DNA
O	O	O	852	857	proto	proto	B-NP	AFX	I-DNA	41	NMOD	I-DNA
O	O	O	857	858	-	-	I-NP	HYPH	I-DNA	41	NMOD	I-DNA
O	O	O	858	866	oncogene	oncogene	B-NP	NN	I-DNA	38	NMOD	I-DNA
O	O	O	866	867	.	.	O	.	O	6	P	O

T10	B-Entity	B-Entity	868	870	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T10	I-Entity	I-Entity	870	871	-	-	I-NP	HYPH	I-protein	6	NMOD	I-protein
T10	I-Entity	I-Entity	871	876	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T10	I-Entity	I-Entity	877	878	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	879	886	binding	binding	I-NP	NN	O	6	NMOD	O
O	O	O	887	895	activity	activity	I-NP	NN	O	7	SUB	O
O	O	O	896	899	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	900	909	inducible	inducible	B-ADJP	JJ	O	7	PRD	O
O	O	O	910	912	by	by	B-PP	IN	O	8	AMOD	O
O	O	O	913	918	tumor	tumor	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	919	927	necrosis	necrosis	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	928	934	factor	factor	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	935	938	and	and	O	CC	O	16	NMOD	O
O	O	O	939	946	phorbol	phorbol	B-NP	NN	O	16	NMOD	O
O	O	O	947	956	myristate	myristate	I-NP	NN	O	16	NMOD	O
O	O	O	957	964	acetate	acetate	I-NP	NN	O	9	PMOD	O
O	O	O	965	967	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	968	971	PLB	PLB	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	O	971	972	-	-	B-NP	HYPH	I-cell_line	20	P	I-cell_line
O	O	O	972	975	985	985	I-NP	CD	I-cell_line	17	PMOD	I-cell_line
O	O	O	975	976	.	.	O	.	O	7	P	O

O	O	O	977	984	However	However	B-ADVP	RB	O	19	VMOD	O
O	O	O	984	985	,	,	O	,	O	19	P	O
O	O	O	986	988	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	989	992	PLB	PLB	B-NP	NN	B-cell_line	7	NMOD	B-cell_line
O	O	O	992	993	-	-	B-NP	HYPH	I-cell_line	7	NMOD	I-cell_line
O	O	O	993	997	IIIB	IIIB	I-NP	NN	I-cell_line	7	NMOD	I-cell_line
O	O	O	998	1003	cells	cell	I-NP	NNS	I-cell_line	3	PMOD	I-cell_line
O	O	O	1003	1004	,	,	O	,	O	19	P	O
O	O	O	1005	1017	constitutive	constitutive	B-NP	JJ	O	10	NMOD	O
O	O	O	1018	1028	expression	expression	I-NP	NN	O	19	SUB	O
O	O	O	1029	1031	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1032	1033	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	1034	1039	novel	novel	I-NP	JJ	O	18	NMOD	O
T11	B-Entity	B-Entity	1040	1042	NF	NF	I-NP	NN	B-protein	18	NMOD	B-protein
T11	I-Entity	I-Entity	1042	1043	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T11	I-Entity	I-Entity	1043	1048	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T11	I-Entity	I-Entity	1049	1050	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
T11	I-Entity	I-Entity	1051	1058	complex	complex	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	1059	1062	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1063	1071	detected	detect	I-VP	VBN	O	19	VC	O
O	O	O	1071	1072	,	,	O	,	O	20	P	O
O	O	O	1073	1081	composed	compose	B-VP	VBN	O	20	VMOD	O
O	O	O	1082	1084	of	of	B-PP	IN	O	22	VMOD	O
O	O	O	1085	1093	proteins	protein	B-NP	NNS	O	23	PMOD	O
O	O	O	1094	1101	ranging	range	B-VP	VBG	O	24	NMOD	O
O	O	O	1102	1109	between	between	B-PP	IN	O	25	VMOD	O
O	O	O	1110	1112	70	70	B-NP	CD	O	29	AMOD	O
O	O	O	1113	1116	and	and	O	CC	O	29	AMOD	O
O	O	O	1117	1120	110	110	B-NP	CD	O	30	NMOD	O
O	O	O	1121	1123	kD	kD	I-NP	NN	O	26	PMOD	O
O	O	O	1123	1124	.	.	O	.	O	19	P	O

O	O	O	1125	1130	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1131	1139	proteins	protein	I-NP	NNS	O	3	SUB	O
O	O	O	1140	1150	interacted	interact	B-VP	VBD	O	0	ROOT	O
O	O	O	1151	1163	specifically	specifically	B-ADVP	RB	O	3	VMOD	O
O	O	O	1164	1168	with	with	B-PP	IN	O	3	VMOD	O
O	O	O	1169	1172	the	the	B-NP	DT	O	12	NMOD	O
T12	B-Entity	B-Entity	1173	1182	symmetric	symmetric	I-NP	JJ	O	12	NMOD	O
T12,T13	I-Entity,B-Entity	I-Entity,B-Entity	1183	1185	NF	NF	I-NP	NN	O	12	NMOD	O
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	1185	1186	-	-	B-NP	HYPH	O	12	NMOD	O
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	1186	1191	kappa	kappa	I-NP	NN	B-DNA	12	NMOD	B-DNA
T12,T13	I-Entity,I-Entity	I-Entity,I-Entity	1192	1193	B	B	I-NP	NN	I-DNA	12	NMOD	I-DNA
T12	I-Entity	I-Entity	1194	1198	site	site	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	1199	1203	from	from	B-PP	IN	O	12	NMOD	O
O	O	O	1204	1207	the	the	B-NP	DT	O	22	NMOD	O
T3	B-Protein	B-Protein	1208	1218	interferon	interferon	I-NP	NN	B-DNA	16	NMOD	B-DNA
T3	I-Protein	I-Protein	1219	1223	beta	beta	I-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	O	1224	1225	(	(	O	(	I-DNA	21	DEP	I-DNA
T4	B-Protein	B-Protein	1225	1228	IFN	IFN	B-NP	NN	I-DNA	20	NMOD	I-DNA
T4	I-Protein	I-Protein	1228	1229	-	-	O	HYPH	I-DNA	20	P	I-DNA
T4	I-Protein	I-Protein	1229	1233	beta	beta	O	SYM	I-DNA	21	DEP	I-DNA
O	O	O	1233	1234	)	)	O	)	I-DNA	16	NMOD	I-DNA
T14	B-Entity	B-Entity	1235	1243	promoter	promoter	B-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	O	1243	1244	.	.	O	.	O	3	P	O

O	O	O	1245	1254	Mutations	Mutation	B-NP	NNS	O	13	SUB	O
O	O	O	1255	1264	affecting	affect	B-VP	VBG	O	1	NMOD	O
O	O	O	1265	1268	the	the	B-NP	DT	O	7	NMOD	O
T15	B-Entity	B-Entity	1269	1270	5	5	I-NP	CD	B-DNA	7	NMOD	B-DNA
T15	I-Entity	I-Entity	1270	1271	'	'	I-NP	SYM	I-DNA	7	NMOD	I-DNA
T15	I-Entity	I-Entity	1272	1279	guanine	guanine	I-NP	NN	I-DNA	7	NMOD	I-DNA
T15	I-Entity	I-Entity	1280	1288	residues	residue	I-NP	NNS	I-DNA	2	OBJ	I-DNA
O	O	O	1289	1291	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1292	1295	the	the	B-NP	DT	O	12	NMOD	O
T16	B-Entity	B-Entity	1296	1301	kappa	kappa	I-NP	NN	B-DNA	12	NMOD	B-DNA
T16	I-Entity	I-Entity	1302	1303	B	B	I-NP	NN	I-DNA	12	NMOD	I-DNA
T16	I-Entity	I-Entity	1304	1308	site	site	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	O	1309	1313	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1314	1320	unable	unable	B-ADJP	JJ	O	13	PRD	O
O	O	O	1321	1323	to	to	B-VP	TO	O	16	VMOD	O
O	O	O	1324	1331	compete	compete	I-VP	VB	O	14	AMOD	O
O	O	O	1332	1335	for	for	B-PP	IN	O	16	VMOD	O
O	O	O	1336	1341	these	these	B-NP	DT	O	22	NMOD	O
T17	B-Entity	B-Entity	1342	1344	NF	NF	I-NP	NN	B-protein	22	NMOD	B-protein
T17	I-Entity	I-Entity	1344	1345	-	-	O	HYPH	I-protein	22	P	I-protein
T17	I-Entity	I-Entity	1345	1350	kappa	kappa	B-NP	NN	I-protein	22	NMOD	I-protein
T17	I-Entity	I-Entity	1351	1352	B	B	I-NP	NN	I-protein	24	AMOD	I-protein
O	O	O	1352	1353	-	-	B-NP	HYPH	O	22	P	O
O	O	O	1353	1360	related	relate	I-NP	VBN	O	25	NMOD	O
O	O	O	1361	1369	proteins	protein	I-NP	NNS	O	17	PMOD	O
O	O	O	1369	1370	.	.	O	.	O	13	P	O

O	O	O	1371	1383	Inducibility	Inducibility	B-NP	NN	O	12	SUB	O
O	O	O	1384	1386	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1387	1397	endogenous	endogenous	B-NP	JJ	B-protein	4	NMOD	B-protein
T5	B-Protein	B-Protein	1398	1401	IFN	IFN	I-NP	NN	I-protein	6	NMOD	I-protein
T5	I-Protein	I-Protein	1401	1402	-	-	O	HYPH	O	6	P	O
T5	I-Protein	I-Protein	1402	1406	beta	beta	B-NP	SYM	O	11	NMOD	O
O	O	O	1407	1410	and	and	O	CC	O	11	NMOD	O
T6	B-Protein	B-Protein	1411	1414	IFN	IFN	B-NP	NN	B-protein	11	NMOD	B-protein
T6	I-Protein	I-Protein	1414	1415	-	-	O	HYPH	O	11	NMOD	O
T6	I-Protein	I-Protein	1415	1420	alpha	alpha	B-NP	SYM	B-RNA	11	NMOD	B-RNA
O	O	O	1421	1424	RNA	RNA	I-NP	NN	I-RNA	2	PMOD	I-RNA
O	O	O	1425	1428	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1429	1433	also	also	I-VP	RB	O	12	VMOD	O
O	O	O	1434	1443	increased	increase	I-VP	VBN	O	12	VC	O
O	O	O	1444	1446	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	1447	1450	PLB	PLB	B-NP	NN	B-cell_line	19	NMOD	B-cell_line
O	O	O	1450	1451	-	-	B-NP	HYPH	I-cell_line	19	NMOD	I-cell_line
O	O	O	1451	1455	IIIB	IIIB	I-NP	NN	I-cell_line	19	NMOD	I-cell_line
O	O	O	1456	1461	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	O	1461	1462	.	.	O	.	O	12	P	O

O	O	O	1463	1468	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1469	1476	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	1477	1485	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1486	1490	that	that	B-SBAR	IN	O	21	DEP	O
O	O	O	1491	1494	HIV	HIV	B-NP	NN	O	8	NMOD	O
O	O	O	1494	1495	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	1495	1496	1	1	I-NP	CD	O	8	NMOD	O
O	O	O	1497	1506	infection	infection	I-NP	NN	O	12	SUB	O
O	O	O	1507	1509	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1510	1526	myelomonoblastic	myelomonoblastic	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	1527	1532	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	1533	1536	may	may	B-VP	MD	O	4	SBAR	O
O	O	O	1537	1543	select	select	I-VP	VB	O	12	VC	O
O	O	O	1544	1547	for	for	B-PP	IN	O	13	VMOD	O
O	O	O	1548	1549	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	1550	1554	more	more	I-NP	RBR	O	17	AMOD	O
O	O	O	1555	1561	mature	mature	I-NP	JJ	O	19	NMOD	O
O	O	O	1562	1571	monocytic	monocytic	I-NP	JJ	O	19	NMOD	O
O	O	O	1572	1581	phenotype	phenotype	I-NP	NN	O	14	PMOD	O
O	O	O	1582	1585	and	and	O	CC	O	21	DEP	O
O	O	O	1586	1590	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1591	1597	unique	unique	B-NP	JJ	O	24	NMOD	O
O	O	O	1598	1605	subunit	subunit	I-NP	NN	O	24	NMOD	O
O	O	O	1606	1618	associations	association	I-NP	NNS	O	33	SUB	O
O	O	O	1619	1621	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	1622	1624	NF	NF	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	O	1624	1625	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
O	O	O	1625	1630	kappa	kappa	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	1631	1632	B	B	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	1633	1636	DNA	DNA	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	1637	1644	binding	binding	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	1645	1653	proteins	protein	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	O	1654	1657	may	may	B-VP	MD	O	21	SBAR	O
O	O	O	1658	1668	contribute	contribute	I-VP	VB	O	33	VC	O
O	O	O	1669	1671	to	to	B-PP	TO	O	34	VMOD	O
O	O	O	1672	1684	differential	differential	B-NP	JJ	O	44	NMOD	O
T18	B-Entity	B-Entity	1685	1687	NF	NF	I-NP	NN	B-protein	40	NMOD	B-protein
T18	I-Entity	I-Entity	1687	1688	-	-	B-VP	HYPH	I-protein	40	P	I-protein
T18	I-Entity	I-Entity	1688	1693	kappa	kappa	B-NP	NN	I-protein	40	NMOD	I-protein
T18	I-Entity	I-Entity	1694	1695	B	B	I-NP	NN	I-protein	44	NMOD	I-protein
O	O	O	1695	1696	-	-	B-NP	HYPH	O	44	NMOD	O
O	O	O	1696	1704	mediated	mediate	I-NP	VBN	O	44	NMOD	O
O	O	O	1705	1709	gene	gene	I-NP	NN	O	44	NMOD	O
O	O	O	1710	1720	expression	expression	I-NP	NN	O	35	PMOD	O
O	O	O	1720	1721	.	.	O	.	O	3	P	O
